%0 Generic
%B Respir Med
%D 2019
%P 105859
%R 10.1016/j.rmed.2019.105859
%T One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting beta2-agonist in UK primary care settings
%V 162